Jitse Niesen dbdf7ee942 Use 'Release' as default when build type is not specified. ...

Otherwise, "cmake /path/to/eigen/" in an empty build directory, as specified
on the CMake page on the wiki, yields a fatal error.

2010-10-22 12:23:35 +01:00

bench

rename PlanarRotation -> JacobiRotation

2010-10-19 21:56:26 -04:00

blas

rename PlanarRotation -> JacobiRotation

2010-10-19 21:56:26 -04:00

cmake

fix bug i just introduced in ei_add_test_internal

2010-10-17 11:47:59 -04:00

debug

Improved the fixed size array display.

2010-10-20 11:56:29 +02:00

demos

Fixed Geometry module failures.

2010-08-17 20:03:50 +02:00

doc

Improved I13_FunctionsTakingEigenTypes.dox.

2010-10-21 10:14:23 +02:00

Eigen

Fixed bug #84.

2010-10-21 10:13:17 +02:00

scripts

finish the change of adding .sh extensions to scripts

2010-05-30 15:58:11 -04:00

test

rename PlanarRotation -> JacobiRotation

2010-10-19 21:56:26 -04:00

unsupported

rename PlanarRotation -> JacobiRotation

2010-10-19 21:56:26 -04:00

.hgignore

fix some warnings

2010-05-22 19:17:04 +02:00

.krazy

* Add Hyperplane::transform(Matrix/Transform)

2008-08-31 13:32:29 +00:00

CMakeLists.txt

Use 'Release' as default when build type is not specified.

2010-10-22 12:23:35 +01:00

COPYING.GPL

there's no reason why we should follow the FSF's stupid recommendation for the naming of these files, right? This could give the wrong impression that Eigen is only GPL-licensed.

2009-11-14 23:26:07 -05:00

COPYING.LGPL

add SSE path for Matrix4f inverse, taken from Intel except that we do a kosher

2009-12-14 22:47:14 -05:00

CTestConfig.cmake

Raise the error/warning limit.

2010-06-20 22:38:36 +02:00

eigen3.pc.in

* eigen2->eigen3

2009-11-19 12:09:04 -05:00

INSTALL

finally, the right fix: set CTEST_BUILD_TARGET.

2009-10-04 20:27:44 -04:00

signature_of_eigen3_matrix_library

improve the scripts for building unit tests:

2009-11-25 21:26:37 -05:00

Description

No description provided

MPL-2.0 147 MiB

Languages

C++ 85.1%

Fortran 8.5%

C 2.7%

CMake 1.9%

Cuda 1.2%

Other 0.4%